Dianthus Therapeutics, Inc. DNTH

Full chart Compare
Set alert

Price alert · DNTH

All alert types
83.61 USD -2.20 (-2.56%)

Nov 5, 2026, 3:54 PM EST

80.34 Day range 85.87
33.85 52-week range 117.88
YTD
+102.89%
1 year
+147.88%

Revenue & Expenses

Other Income → Expenses: $15.60MExpenses → Selling, General & Admin: $34.33MExpenses → Research & Development: $145.64MGross Profit → Expenses: $2.04MRevenue → Gross Profit: $2.04MNet Loss → Expenses: $162.34MOther Income$15.60MGross Profit$2.04MNet Loss$162.34MExpenses$179.97MSelling, General & Admin$34.33MResearch & Development$145.64MRevenue$2.04M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

DNTH annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
2.04M6.24M2.83M6.42M0
2.04M6.24M2.83M6.42M0
2.04M6.24M2.83M6.42M0
179.97M108.10M51.00M36.12M74.69M
145.64M83.11M32.84M29.38M46.77M
34.33M24.99M18.16M6.74M27.93M
-177.93M-101.86M-48.17M-29.70M-74.69M
-162.34M-84.97M-43.55M-28.48M-71.14M
-162.34M-84.97M-43.55M-28.48M-71.14M
-162.34M-84.97M-43.55M-28.48M-71.14M
-162.34M-84.97M-43.55M-28.48M-71.14M
-4.20-2.55-8.45-32.57-20.60
-4.20-2.55-8.45-32.57-20.60
-4.20-2.55-8.45-32.57-20.60
-162.34M-84.97M-43.55M-28.48M-71.14M
-162.34M-84.97M-43.55M-28.48M-71.14M
38.62M33.31M5.15M874.23K3.43M
38.62M33.31M5.15M874.23K3.43M